YD Bio Limited Ordinary Shares (YDES) Stock Analysis

What YD Bio Limited Ordinary Shares does

Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.

Key metrics

ETFs linked to YDES

Broad-market and Healthcare sector ETFs an investor holding YD Bio Limited Ordinary Shares is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how YDES fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for YD Bio Limited Ordinary Shares?

YD Bio Limited Ordinary Shares trades under the ticker YDES on NASDAQ.

Which exchange is YDES listed on?

YDES is listed on NASDAQ.

What sector does YD Bio Limited Ordinary Shares operate in?

YD Bio Limited Ordinary Shares is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze YDES in a portfolio?

PortView shows YDES's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.